Nivolumab Plus Radiotherapy in Advanced Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions
Melanoma
Interventions
BIOLOGICAL

Nivolumab

Injection of nivolumab

RADIATION

hypofractionned radiotherapy

radiation

Trial Locations (14)

Unknown

CHU d'Amiens, Amiens

CH d'Annecy, Annecy

CHRU de Besançon, Besançon

Hôpital Ambroise Paré, Boulogne-Billancourt

Hôpital Avicenne, Boulogne-Billancourt

CHU Hôpital Clemenceau, Caen

CHU de Clermont Ferrand, Clermont-Ferrand

CHRU de Lille, Lille

Hôpital Dupuytren, Limoges

Hospices civiles de Lyon, Lyon

CHU La Timone, Marseille

Hôpital St Louis, Paris

CHU de Rouen, Rouen

06200

CHU de NIce, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02799901 - Nivolumab Plus Radiotherapy in Advanced Melanoma | Biotech Hunter | Biotech Hunter